Canada markets open in 18 minutes

  • S&P/TSX
    15,670.70
    +84.13(+0.54%)

  • S&P 500
    3,310.11
    +39.08(+1.19%)

  • DOW
    26,659.11
    +139.16(+0.52%)

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.49-0.43 (-3.94%)
At close: 4:00PM EDT

10.50 +0.01 (0.10%)
Before hours: 9:10AM EDT

Currency in USD

Valuation Measures

Market Cap (intraday) 51.76B
Enterprise Value 31.49B
Trailing P/E N/A
Forward P/E 1-22.32
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)641.15
Price/Book (mrq)8.94
Enterprise Value/Revenue 3542.45
Enterprise Value/EBITDA 6-13.93

Trading Information

Stock Price History

Beta (5Y Monthly) 1.02
52-Week Change 3360.09%
S&P500 52-Week Change 37.93%
52 Week High 333.79
52 Week Low 32.12
50-Day Moving Average 312.74
200-Day Moving Average 315.20

Share Statistics

Avg Vol (3 month) 317.94M
Avg Vol (10 day) 35.97M
Shares Outstanding 5167.52M
Float 164.19M
% Held by Insiders 12.69%
% Held by Institutions 129.41%
Shares Short (Oct. 14, 2020) 455.04M
Short Ratio (Oct. 14, 2020) 42.19
Short % of Float (Oct. 14, 2020) 433.54%
Short % of Shares Outstanding (Oct. 14, 2020) 432.85%
Shares Short (prior month Sep. 14, 2020) 457.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jun. 05, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,045.74%

Management Effectiveness

Return on Assets (ttm)-22.79%
Return on Equity (ttm)-184.48%

Income Statement

Revenue (ttm)2.74M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)96.90%
Gross Profit (ttm)-82.01M
EBITDA -106.74M
Net Income Avi to Common (ttm)-222M
Diluted EPS (ttm)-1.85
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)371.66M
Total Cash Per Share (mrq)2.22
Total Debt (mrq)101.02M
Total Debt/Equity (mrq)54.21
Current Ratio (mrq)10.06
Book Value Per Share (mrq)1.17

Cash Flow Statement

Operating Cash Flow (ttm)-94.08M
Levered Free Cash Flow (ttm)-51.83M